Results 251 to 260 of about 2,674,072 (303)

Pharmacological treatment patterns, factors associated with glycemic control, and renal function parameters in a real-world cohort of Hispanic adults with type 2 diabetes. [PDF]

Biomed Rep
Diaz-Martinez J, Duran C, Hospital M, Hernández-Fuentes GA, Rojas-Larios F, Kallus L, Mancilla J, Jean-Pierre A, Barthe A, Madruga-Reyes Y, Parra-Vidal L, Wagner E, Bursac Z, Montesinos-López OA, Delgado-Enciso I.   +14 more
europepmc   +1 more source

Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. [PDF]

Drug Saf
Bea S, Patorno E, Hahn G, Paik JM, Wexler DJ, Bykov K.   +5 more
europepmc   +1 more source

Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4. [PDF]

Diabetes Obes Metab
Guan H, Jiang H, Yuan H, Sun J, Xu J, Ji L.   +5 more
europepmc   +1 more source

Delayed-Onset Hypoglycemia After Levofloxacin Use in a Diabetic Patient. [PDF]

Case Rep Med
Dwaah H, Tupchong S, Kim J.
europepmc   +1 more source

Impact of renal function on antidiabetic drug selection in Japan: A real-world analysis using the J-DREAMS database. [PDF]

J Diabetes Investig
Kubota M, Ohsugi M, Ueki K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epac2: a sulfonylurea receptor?

Biochemical Society Transactions, 2012
Sulfonylureas are widely used oral drugs in the treatment of diabetes mellitus. They function by the inhibition of ATP-sensitive K+ channels in pancreatic β-cells, which are thus considered the ‘classical’ sulfonylurea receptor. Next to the ATP-sensitive K+ channels, additional sulfonylurea-interacting proteins were identified, which might contribute ...
H. Rehmann
openaire   +3 more sources

Modification of the Mitochondrial Sulfonylurea Receptor by Thiol Reagents

Biochemical and Biophysical Research Communications, 1999
The purpose of this study was to investigate the effects exerted by thiol-modifying reagents on themitochondrial sulfonylurea receptor. The thiol-oxidizing agents (timerosal and 5, 5'-dithio-bis(2-nitrobenzoic acid)) were found to produce a large inhibition (70% to 80%) of specific binding of [(3)H]glibenclamide to the beef heart mitochondrial membrane.
Adam Szewczyk, Maciej J Nalecz
exaly   +3 more sources

The sulfonylurea receptor Sur is dispensable for chitin synthesis in Drosophila melanogaster embryos.

Pest Management Science, 2013
Background: Chitin produced by membrane-inserted chitin synthases is an important constituent of the arthropod cuticle and midgut peritrophic matrix. Chitin synthesis inhibitors are common insecticides in pest control.
Frauke Meyer, M. Flötenmeyer, B. Moussian   +2 more
semanticscholar   +2 more sources

Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I. Binding characteristics [PDF]

Biochimica Et Biophysica Acta - Biomembranes, 1994
Glimepiride is a novel sulfonylurea drug for treatment of non-insulin-dependent diabetes mellitus with higher blood sugar lowering efficacy in diabetic patients than glibenclamide raising the question whether this characteristics is in line with ...
Gunter Müller, Werner Kramer
exaly   +2 more sources

Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.

Cancer Letters, 2022
Cancer-associated fibroblasts (CAFs) play a pivotal role in cancer progression; however, how CAFs are induced remains elusive. Sulfonylurea receptor 1 (SUR1) is a tumor-enhancer in non-small cell lung carcinoma (NSCLC).
Hongling Chen, Li Zhao, Yuting Meng, Xixi Qian, Ya Fan, Quanli Zhang, Chao Wang, Fan Lin, B. Chen, Lin Xu, Wenbin Huang, Jing Chen, Xuerong Wang   +12 more
semanticscholar   +1 more source